Attovia Therapeutics
Thea Hawkins is an accomplished Outsourcing & Contract Management Consultant at SC Hawkins Consulting LLC since March 2019, bringing extensive experience in clinical and contract management across various prominent organizations. Previous roles include Associate Director of Clinical Business Operations at Nuvation Bio, Sr. Clinical Contracts Manager and Clinical Contract Manager at Nektar Therapeutics, and Sr. Contracts Associate at Pharmacyclics. Thea has a solid foundational background at Genentech, where positions ranged from Contract Associate II to Quality Control Co-Op. Thea holds a Paralegal Certification from the University of California Berkeley, Extension, and has a degree from San Francisco State University.
This person is not in any teams
Attovia Therapeutics
Attovia is creating a pipeline of biotherapeutics with an initial focus on immune-mediated disease and oncology. We leverage ATTOBODY, a novel biologics platform, to generate small format biparatopic binders that unlock the spatial aspect of target engagement. The biparatopic binding mode of ATTOBODIES translates to picomolar affinity with glue-like off-rates, exquisite specificity, and accelerated target internalization. Their small format and modularity offer fast tissue penetration, ease of engineering into bispecifics, and tunable half-life from hours to weeks. Collectively, these properties of ATTOBODIES expand the addressable target and epitope universe across disease areas and can offer stronger efficacy, faster speed to response, and an improved safety profile compared to traditional approaches. By utilizing our ATTOBODY technology, we will develop novel medicines that target unaddressed elements of disease, as well as offer better efficacy and tolerability. We envision a world where no patient is left behind.